ScoreComparison
Why is Emergent BioSolutions, Inc. ?
1
Poor long term growth as Operating profit has grown by an annual rate -16.76% of over the last 5 years
2
Positive results in Jun 25
- OPERATING CASH FLOW(Y) Highest at USD 169 MM
- NET PROFIT(HY) Higher at USD 53.95 MM
- ROCE(HY) Highest at 30.24%
3
With ROE of -15.10%, it has a risky valuation with a 0.67 Price to Book Value
- Over the past year, while the stock has generated a return of 24.87%, its profits have fallen by -344%
4
Market Beating Performance
- The stock has generated a return of 24.87% in the last 1 year, much higher than market (S&P 500) returns of 12.94%
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Emergent BioSolutions, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Emergent BioSolutions, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Emergent BioSolutions, Inc.
27.78%
0.87
93.96%
S&P 500
13.22%
0.64
20.20%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-7.53%
EBIT Growth (5y)
-16.76%
EBIT to Interest (avg)
4.18
Debt to EBITDA (avg)
4.15
Net Debt to Equity (avg)
0.93
Sales to Capital Employed (avg)
0.74
Tax Ratio
100.00%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
87.29%
ROCE (avg)
9.11%
ROE (avg)
7.50%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.67
EV to EBIT
-17.79
EV to EBITDA
14.99
EV to Capital Employed
0.83
EV to Sales
0.91
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-4.65%
ROE (Latest)
-15.10%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend17What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD 169 MM
NET PROFIT(HY)
Higher at USD 53.95 MM
ROCE(HY)
Highest at 30.24%
RAW MATERIAL COST(Y)
Fallen by -277.72% (YoY
DEBT-EQUITY RATIO
(HY)
Lowest at 75.55 %
DEBTORS TURNOVER RATIO(HY)
Highest at 6.17 times
-16What is not working for the Company
PRE-TAX PROFIT(Q)
At USD -17.9 MM has Fallen at -438.35%
INVENTORY TURNOVER RATIO(HY)
Lowest at 1.4 times
NET SALES(Q)
Lowest at USD 140.9 MM
Here's what is working for Emergent BioSolutions, Inc.
Net Profit
At USD 53.95 MM has Grown at 123.49%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very positive
Net Profit (USD MM)
Operating Cash Flow
Highest at USD 169 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Net Profit
Higher at USD 53.95 MM
than preceding 12 month period ended Jun 2025MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (USD MM)
Debt-Equity Ratio
Lowest at 75.55 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Debtors Turnover Ratio
Highest at 6.17 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Raw Material Cost
Fallen by -277.72% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Emergent BioSolutions, Inc.
Net Sales
At USD 140.9 MM has Fallen at -41.62%
over average net sales of the previous four periods of USD 241.35 MMMOJO Watch
Near term sales trend is extremely negative
Net Sales (USD MM)
Pre-Tax Profit
At USD -17.9 MM has Fallen at -438.35%
over average net sales of the previous four periods of USD -3.33 MMMOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (USD MM)
Net Sales
Lowest at USD 140.9 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (USD MM)
Inventory Turnover Ratio
Lowest at 1.4 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
